Fibrin stabilization (factor XIII), fibrin structure and thrombosis

被引：35
作者：
Bereczky, Z
Katona, É
Muszbek, L
机构：
[1] Univ Debrecen, Med & Hlth Sci Ctr, Clin Res Ctr, Hungarian Acad Sci, H-4012 Debrecen, Hungary
[2] Univ Debrecen, Med & Hlth Sci Ctr, Thrombosis Res Grp, Hungarian Acad Sci, H-4012 Debrecen, Hungary
来源：
PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 2003年 / 33卷 / 5-6期
关键词：
factor XIII; factor XIII-A Val34Leu polymorphism; fibrinolysis; thrombosis;
D O I：
10.1159/000083841
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Factor XIII (FXIII) is a zymogen that is converted into an active transglutaminase (FXIIIa) by the concerted action of thrombin and Ca2+. Its main task is to crosslink alpha-, and gamma-chains of fibrin and alpha2-plasmin inhibitor to fibrin. By this way FXlIIa strengthens fibrin and protects it from the prompt elimination by fibrinolytic system. The changes of FXIII level in thrombotic diseases are hardly explored and there are contradictory results concerning the protective effect of Val34Leu polymorphism against arterial or venous thrombosis. The results suggest that the thrombo-protective effect of Leu34 allele prevails only in certain genetic and/or environmental constellations. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码：430 / 437
页数：8
相关论文
共 108 条
[31]   FIBRIN CROSSLINKS AND LYSIS RATES [J].
GAFFNEY, PJ ;
WHITAKER, AN .
THROMBOSIS RESEARCH, 1979, 14 (01) :85-94
[32]   A common mutation in the gene for coagulation factor XIII-A (Val34Leu): A risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases [J].
Gemmati, D ;
Serino, ML ;
Ongaro, A ;
Tognazzo, S ;
Moratelli, S ;
Resca, R ;
Moretti, M ;
Scapoli, GL .
AMERICAN JOURNAL OF HEMATOLOGY, 2001, 67 (03) :183-188
[33]   ENZYMIC LYSIS OF PLASMA CLOTS - INFLUENCE OF FIBRIN STABILIZATION ON LYSIS RATES [J].
GORMSEN, J ;
FLETCHER, AP ;
ALKJAERSIG, N ;
SHERRY, S .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1967, 120 (03) :654-+
[34]  
HAVERKATE F, 1975, THROMB DIATH HAEMOST, V34, P584
[35]   Genetic variants of the hemostatic system and development of transplant coronary artery disease [J].
He, JQ ;
Gaur, LK ;
Stempien-Otero, A ;
Nelson, K ;
Levy, WC ;
O'Brien, KD ;
Bolgiano, DC ;
Reiner, AP .
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2002, 21 (06) :629-636
[36]   MECHANISM OF ENHANCED STREPTOKINASE-INDUCED CLOT LYSIS FOLLOWING IN-VITRO FACTOR-12 INACTIVATION [J].
HENDERSON, KW ;
NUSSBAUM, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1969, 17 (05) :445-+
[37]  
Hevessy Z, 1996, THROMB HAEMOSTASIS, V75, P161
[38]   REVERSIBLE CROSS-LINKING OF ALPHA-2-PLASMIN INHIBITOR TO FIBRINOGEN BY FIBRIN-STABILIZING FACTOR [J].
ICHINOSE, A ;
AOKI, N .
BIOCHIMICA ET BIOPHYSICA ACTA, 1982, 706 (02) :158-164
[39]  
Ichinose A, 2001, THROMB HAEMOSTASIS, V86, P57
[40]   Coagulation factor deficiencies and pregnancy loss [J].
Inbal, A ;
Muszbek, L .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2003, 29 (02) :171-174
12345678910